Duglimax (metformin hydrochloride) tablets 500 mg/1 mg. №60

$24.00

Manufacturer: Ukraine

Purpose: Lowers blood sugar levels in type 2 diabetes patients.

SKU: MED58009 Category:

Description

Duglimax (metformin hydrochloride) tablets 500 mg/1 mg. №60

Ingredients

Active ingredient: Metformin hydrochloride
Other ingredients: microcrystalline cellulose, povidone, magnesium stearate, hypromellose, titanium dioxide, polyethylene glycol.

Dosage

Dosage: The usual dose is 500 mg once a day with the evening meal. Dosage may vary based on individual needs and as directed by a healthcare provider.

Indications

Indications: Duglimax tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Contraindications

Contraindications: Do not use Duglimax if you have severe kidney disease or metabolic acidosis. Consult a healthcare provider before use if pregnant or breastfeeding.

Directions

Directions: Take Duglimax tablets exactly as prescribed by your healthcare provider. Swallow the tablets whole with a full glass of water.

Scientific Evidence

Scientific Evidence: Studies have shown that metformin, the active ingredient in Duglimax, works by decreasing glucose production in the liver and improving insulin sensitivity in the body. This helps lower blood sugar levels and improve overall glycemic control in patients with type 2 diabetes.

Additional Information

Additional Information: It is important to monitor blood sugar levels regularly while taking Duglimax to ensure optimal control. Inform your healthcare provider of any changes in your health status or medication regimen.

Metformin hydrochloride, the key component of Duglimax tablets, is a first-line medication for the treatment of type 2 diabetes. It belongs to the biguanide class of drugs and is known for its ability to reduce hepatic glucose production and increase peripheral glucose uptake, leading to improved insulin sensitivity.

Clinical trials have demonstrated the efficacy of metformin in not only lowering blood glucose levels but also in reducing the risk of cardiovascular complications associated with diabetes. Research published in the New England Journal of Medicine has highlighted the cardiovascular benefits of metformin therapy, making it a preferred choice in diabetes management.